• Members of the previous forum can retrieve their temporary password here, (login and check your PM).

Reflections on P. cubensis and other species

Can’t really say much from a microdose but they seem to work. I’m feeling .06 grams very slightly. It’s nice. I have a lot of work to do next few hours so hopefully I’m in the zone.
 
So is it the consensus now that Psilocybe cubensis is not of old world origin and instead native to the americas? What I’m reading is Natalensis and Ochraceocentrata make up the “cubensis” in South Africa?? What about that tapestry found along Silk Road apparently depicting a soma ceremony(and a mushroom) people relate to cubensis?


What about hypothetical cubes in Egypt? Should we be calling them something else? Nats?

This is the first time I’m hearing that cubes are native to the americas..



It sounds like no one really knows for sure?
 
I really do Love my lsd but oh boy to me there is no better "visual & mystical" trip than that of..(of course all mushrooms are teachers to me) than Panaeolus Cyanescens!
I love some PE too! Pans being a bit more intense visually, yet absolutely astonishing!

Penis Envy I think is still one of the cubensis strains I think? Either way I barely get any body load from pe and the visuals(especially CEV), are just WOW. I only see these types of visuals when eating PE and Pans are usually 1 to 2x stronger..with PE being something like 2grams feels and visually seems more like around 4.5. 2 grams of Pans get me dangerously close to CEV that I would usually get on about 6-7 grams of cubensis.

Love them and I believe I have had Azures or Orca possibly...Either way mushrooms 🍄 win, no matter what strain or species.
 
Every strain of cubensis I've tried has had different results. I definitely feel like you get tailored experiences based on the cubensis strains you try. We're living such a beautiful time where it is so accessible now. I got into growing last year and have grown some really cool species already. I have lucid gates as well as tidal wave coming up soon to try out 🔥🤘
 
Amazonian Cubensis is widely known as a unique psilocybin mushroom strain often discussed in mycology communities for its origin and characteristics.
 
Does anyone have more information on the actual alkaloid profile of ochraceocentratas? Especially compared to others like cubensis and pan cyans etc?

These mushrooms do for sure feel a bit different. It could still be placebo but they really do feel cleaner and crisper than cubes, and are super euphoric with less stomach cramping. Probly twice the potency of my PE6 cubensis I would say. I learned to not microdose them like cubes because I just ended up lightly tripping.

But why? What makes these mushrooms this way aside from potency? What is making cubes less pleasant for so many?
 
Does anyone have more information on the actual alkaloid profile of ochraceocentratas? Especially compared to others like cubensis and pan cyans etc?

These mushrooms do for sure feel a bit different. It could still be placebo but they really do feel cleaner and crisper than cubes, and are super euphoric with less stomach cramping. Probly twice the potency of my PE6 cubensis I would say. I learned to not microdose them like cubes because I just ended up lightly tripping.

But why? What makes these mushrooms this way aside from potency? What is making cubes less pleasant for so many?
We'll have to see if a detailed and sensitive analysis of ochraceocentrata yields any traces of, say, β-carbolines on top of a higher psiloc(yb)in potency. As we know, β-carbolines have been found in other Psilocybe species before. It's a bit harder to definitively pinpoint the factors underlying variations in subjective effects.
 
We'll have to see if a detailed and sensitive analysis of ochraceocentrata yields any traces of, say, β-carbolines on top of a higher psiloc(yb)in potency. As we know, β-carbolines have been found in other Psilocybe species before. It's a bit harder to definitively pinpoint the factors underlying variations in subjective effects.

It's true, but the concentrations at which the beta-carbolines were detected or at tiny trace microgram amounts...for them to become pharmacologically relvant (equivalent to the dosages found in a cup of ayahuasca), psychedelic neurobiologist/chemist/pharmacologist Andrew Gallimore has suggested one would need to consume "around 30kg of dried mycelia or 3 metric tons of the dried mushrooms". However there are a range of other secondary compounds found in these mushrooms, including tryptamine psilocybin analogues such as baeocystin, norbaeocystin, norpsilocin and aeruginascin, the latter’s breakdown metabolite 4 hydroxy-N,N,N-trimethyltryptamine, terpenes, sesquiterpenes and phenylethylamine derivatives, and I think the research has only really scratched the surface so far. Regarding P. ochraceocentrata in particular, there is no clear chemical "smoking gun" in analyses conducted so far indicating what might be responsible for the perceived differences in effect...however some analyses have shown up baeocystin (at higher levels than tends to be detected in P. cubensis; however this varies), and also a number of compounds expressing antioxidant and anti-Inflammatory effects (while the species mentioned in this paper is P. natalensis, it is in fact referring to P. ochraceocentrata prior to the latter having been distinguished from the former).

@Jamie01, your own observations regarding P. ochraceocentrata definitely align with mine. I'm soon to (hopefully) have a study paper published where we netted data from quite a few people about their experiences with different species of psilocybin mushrooms, and the effects profile they attribute to different species. While set and setting factors appeared to be the dominant determinants of experiential outcomes (as one might expect), and while it is obviously hard to rule out expectancy effects, the species consumed accounted for a small but reliable and structured share of variance in the subjective-effect factors in spite of all the variation in set and setting factors between individuals. Interestingly, P. ochraceocentrata was consistently rated gentler on somatic distress and challenging experience (also rating lowest on arousal-related physical items such as heightened alertness and dizziness), while the PE/APE varieties of P. cubensis were rated as somewhat harsher. Several less commonly used species were rated above the relative-liking midpoint of the species consumed, whereas P. cubensis was not. Respondents also reported that they perceived species as qualitatively distinct and deliberately selected some for particular effects. Obviously further research will be needed to pin down what chemistry in the mushrooms might be giving rise to these perceived (but quite consistent) differences in effect.
 
Back
Top Bottom